aTyr Pharma, Inc. Financial Ratios — ATYR Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-80.59	-63.83	-55.05	-56.75	-48.58	-53.08	-43.31	-43.78	-42.91	-46.56	-58.88	-78.09
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	100	- -	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-5,121.33	-140.08	- -	-430.47	-14,781.3	-28,244.26	-40,038.95
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-5,445.02	-152.19	- -	-446.79	-15,557.79	-28,899.57	-40,856.32
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	173.16	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-5,631.04	-155.24	- -	-436.58	-14,276.77	-27,243.4	-39,012.11
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-5,593.13	-155.18	- -	-436.53	-14,274.5	-27,243.83	-39,009.47
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-5,593.13	-155.18	- -	-436.53	-14,274.5	-27,243.83	-39,009.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	7.56	1.68	0.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7	10	5	10	20	16	12	2	1	12	15	13	12
ST Debt	1	5	3	- -	5	8	9	1	1	1	1	1	1
LT Debt	6	5	2	9	15	8	2	1	- -	11	14	12	11
Total Debt/EBITDA	-0.37	-0.45	-0.11	-0.17	-0.42	-0.5	-0.54	-0.15	-0.04	-0.26	-0.29	-0.2	-0.16
Net Debt/EBITDA	1.57	0.16	1.02	0.51	0.03	0.22	0.02	1.16	0.07	0.22	0.43	0.17	0.14
Total Debt/EBIT	-0.35	-0.44	-0.11	-0.16	-0.42	-0.49	-0.51	-0.14	-0.04	-0.25	-0.27	-0.2	-0.16
Net Debt/EBIT	1.51	0.15	1.01	0.5	0.03	0.21	0.02	1.07	0.07	0.22	0.41	0.16	0.14
EBITDA to Interest Expense	- -	-27.31	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-27.61	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-28.31	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-215.65	-533.57	-121.92	-268.19	-295.63	-566.3	-890.63	-874.13	-322.21	-435.98	-387.86	-549.38	-651.66
Long-Term Debt/Equity (%)	- -	- -	1.54	14.65	22.91	24.56	10.65	4.38	0.36	14.93	15.22	17.23	15.7
Long-Term Debt/Capital (%)	-8.05	-5.15	-1.16	-4.46	-6.02	-2.92	-0.72	-0.41	-0.11	-2.62	-3.04	-2.32	-1.78
Long-Term Debt/Total Assets (%)	15.48	24.91	1.37	11.42	16.47	15.67	6.19	3.56	0.34	11.11	11.41	12.42	11.36
Total Debt/Equity (%)	-10.42	-11.29	4.47	15.19	30.71	47.64	55.79	7.11	1.26	16.18	16.69	19.02	17.88
Total Debt/Capital (%)	-9	-10.29	-3.36	-4.62	-8.07	-5.67	-3.78	-0.67	-0.37	-2.84	-3.33	-2.56	-2.02
Total Debt/Total Assets (%)	17.31	49.78	3.97	11.84	22.08	30.39	32.42	5.78	1.19	12.04	12.51	13.72	12.94
Net Debt to Equity	44.75	3.98	-41.62	-45.94	-2.12	-20.6	-2.25	-53.84	-2.14	-14	-24.92	-15.83	-15.97
Net Debt/Capital (%)	26.18	3.18	23.25	11.79	0.51	2.27	0.15	4.8	0.63	2.4	4.74	2.09	1.78
EBITDA	-19	-23	-47	-57	-46	-32	-22	-15	-33	-45	-52	-66	-76
EBITDA-CapEx	-19	-23	-47	-58	-48	-33	-22	-15	-33	-46	-56	-66	-76
Operating Income (Loss)	-20	-24	-48	-58	-47	-33	-23	-16	-34	-46	-55	-68	-78

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7	1.57	7.86	8.46	8.19	4.57	2.41	5.4	17.95	4.77	5.98	4.82	5.19
Current Ratio	7.11	1.63	8.06	8.77	8.37	4.69	2.47	6.06	18.89	5.83	6.27	5.48	5.3
Quick Ratio	7	1.57	7.86	8.46	8.19	4.57	2.42	5.75	18.02	5.62	6.13	4.93	5.25
CFO/Avg Current Liab	- -	-2.98	-3.31	-5.11	-4.48	-2.93	-1.68	-1.63	-5.57	-4.21	-2.19	-4.4	-4.12
Common Equity/Total Assets	-215.65	-533.57	-121.92	-268.19	-295.63	-566.3	-890.63	-874.13	-322.21	-435.98	-387.86	-549.38	-651.66
Long-Term Debt/Equity (%)	- -	- -	1.54	14.65	22.91	24.56	10.65	4.38	0.36	14.93	15.22	17.23	15.7
Long-Term Debt/Capital (%)	-8.05	-5.15	-1.16	-4.46	-6.02	-2.92	-0.72	-0.41	-0.11	-2.62	-3.04	-2.32	-1.78
Long-Term Debt/Total Assets (%)	15.48	24.91	1.37	11.42	16.47	15.67	6.19	3.56	0.34	11.11	11.41	12.42	11.36
Total Debt/Equity (%)	-10.42	-11.29	4.47	15.19	30.71	47.64	55.79	7.11	1.26	16.18	16.69	19.02	17.88
Total Debt/Capital (%)	-9	-10.29	-3.36	-4.62	-8.07	-5.67	-3.78	-0.67	-0.37	-2.84	-3.33	-2.56	-2.02
Total Debt/Total Assets (%)	17.31	49.78	3.97	11.84	22.08	30.39	32.42	5.78	1.19	12.04	12.51	13.72	12.94
CFO/Total Liabilities	-16.35	-20.44	-251.6	-298.26	-168.71	-162.67	-131.99	-211.28	-515.91	-170.95	-110.07	-256.02	-241.05
CFO/CapEx	-26.88	-91.66	-55.42	-88.1	-32.29	-52.29	-253.33	-75.75	-172.27	-25.52	-7.88	-1,063.37	-805.01
Altman's Z-Score	-3.68	-10.86	-2.12	-5.14	-4.85	-9.07	-13.92	-12.4	-4.37	-6.75	-6.07	-3.2	-9.34

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	269	73
- Cash & Cash Equivalents	36	14	53	38	21	23	9	17	2	10	23	11	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	10	5	10	20	16	12	2	1	12	15	13	12
Enterprise Value	-27	-6	-90	-63	-65	-34	-20	-30	-107	-55	-83	210	6
Total Capital	-76	-100	-153	-206	-244	-283	-311	-336	-371	-406	-453	-519	-594
Total Debt/Capital (%)	-9	-10.29	-3.36	-4.62	-8.07	-5.67	-3.78	-0.67	-0.37	-2.84	-3.33	-2.56	-2.02
Total Debt / EV	-0.25	-1.84	-0.06	-0.15	-0.3	-0.48	-0.6	-0.08	-0.01	-0.21	-0.18	0.06	2.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	892.75	31.43
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	269	73
Diluted Enterprise Value	-27	-4	-48	-29	-1	-7	2	-15	-1	1	-8	271	74
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.83	0.06
TTM Sales	- -	- -	- -	- -	- -	- -	- -	10	- -	10	- -	- -	- -
TTM EBITDA	-19	-23	-47	-57	-46	-32	-22	-15	-33	-45	-52	-66	-76
TTM Operating Income	-20	-24	-48	-58	-47	-33	-23	-16	-34	-46	-55	-68	-78
TTM Cash Flow to Firm	-17	-22	-37	-53	-42	-31	-20	-15	-33	-42	-33	-69	-62
TTM Free Cash Flow to Firm	-17	-22	-36	-52	-41	-30	-20	-15	-33	-40	-29	-69	-62

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3.89	-1.18
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-27	-6	-90	-63	-65	-34	-20	-30	-107	-55	-83	210	6
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.42	0.64
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	892.75	31.43
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.7	-4.04
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.62	-9.15
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.65	-0.8
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.51	-0.12
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.49
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.56	-1.12
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.2	-0.1
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.85	1.08
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.48	4.45
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.23	10.07
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.51	0.88
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,143.94	383.25
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	736.7	1,576.28
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,257.7	3,567.7
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	448.73	313.21
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3.89	-1.17
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.5	-4.83
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.28	-10.94
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.53	-0.96
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.51	-4.84
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.28	-10.95
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.53	-0.96
EV/Sales Average	- -	- -	- -	- -	- -	- -	5.6	- -	- -	0.13	- -	745.38	1,582.06
EV/Sales High	- -	- -	- -	- -	- -	- -	5.6	- -	- -	0.13	- -	1,266.39	3,573.48
EV/Sales Low	- -	- -	- -	- -	- -	- -	5.6	- -	- -	0.13	- -	457.41	318.99
EV/EBITDA Average	1.44	0.16	1.02	0.51	0.03	0.22	-0.11	1.02	0.03	-0.03	0.15	-2.64	-3.95
EV/EBITDA High	1.44	0.16	1.02	0.51	0.03	0.22	-0.11	1.02	0.03	-0.03	0.15	-4.48	-8.93
EV/EBITDA Low	1.44	0.16	1.02	0.51	0.03	0.22	-0.11	1.02	0.03	-0.03	0.15	-1.62	-0.8
EV/EBIT Average	1.39	0.15	1.01	0.5	0.03	0.21	-0.1	0.94	0.03	-0.03	0.14	-2.58	-3.87
EV/EBIT High	1.39	0.15	1.01	0.5	0.03	0.21	-0.1	0.94	0.03	-0.03	0.14	-4.38	-8.75
EV/EBIT Low	1.39	0.15	1.01	0.5	0.03	0.21	-0.1	0.94	0.03	-0.03	0.14	-1.58	-0.78
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.62	0.78
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.98	7.29
Enterprise Value Average	-27	-4	-48	-29	-1	-7	2	-15	-1	1	-8	175	301
Enterprise Value High	-27	-4	-48	-29	-1	-7	2	-15	-1	1	-8	298	679
Enterprise Value Low	-27	-4	-48	-29	-1	-7	2	-15	-1	1	-8	107	61

Shares Outstanding	2	2	2	2	2	2	4	11	28	29	63	84	98
Diluted Weighted Avg Shares	1	1	1	2	2	2	3	9	19	28	54	74	93
Basic Weighted Avg Shares	1	1	1	2	2	2	3	9	19	28	54	74	93
Revenue per Share	- -	- -	- -	- -	- -	- -	0.13	1.14	- -	0.37	0.01	- -	- -
EBITDA per Share	-26.17	-31.58	-41.32	-33.72	-25.2	-14.99	-6.44	-1.6	-1.71	-1.57	-0.97	-0.89	-0.82
Operating Income per Share	-27.16	-32.74	-42.09	-34.25	-25.58	-15.34	-6.85	-1.74	-1.78	-1.63	-1.02	-0.91	-0.83
Basic EPS, GAAP	-30.09	-34.42	-42.42	-34.2	-26.16	-16.13	-7.03	-1.77	-1.77	-1.6	-0.94	-0.86	-0.8
Basic EPS from Cont Ops	-27.82	-33.84	-42.4	-34.2	-26.16	-16.13	-7.08	-1.77	-1.77	-1.6	-0.94	-0.86	-0.8
Diluted EPS, GAAP	-30.09	-34.42	-42.42	-34.2	-26.16	-16.13	-7.03	-1.77	-1.77	-1.6	-0.94	-0.86	-0.8
Diluted EPS from Cont Ops	-27.82	-33.84	-42.4	-34.2	-26.16	-16.13	-7.08	-1.77	-1.77	-1.6	-0.94	-0.86	-0.8
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-24.06	-31.72	-32.53	-31.25	-22.99	-14.52	-5.96	-1.67	-1.73	-1.47	-0.62	-0.93	-0.67
Free Cash Flow per Basic Share	-24.95	-32.07	-33.11	-31.61	-23.7	-14.79	-5.99	-1.69	-1.74	-1.53	-0.7	-0.93	-0.67
Cash & Equivalents per Share	50.67	22.03	84.45	42.65	46.19	23.15	9.28	3.46	5.66	2.33	1.83	0.97	0.85
Book Value per Share	-119.25	-153.09	-139.75	-127.67	-143.34	-139.59	-96.05	-36.95	-19.51	-14.69	-8.73	-7.16	-6.52
Tangible Book Value per Share	-91.84	-126.49	101.7	37.13	34.86	15.72	6.27	3.44	5.72	2.51	1.69	0.94	0.72

aTyr Pharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)